Trump doubles down on Most Favored Nation plan to target drug prices
US President Donald Trump has called on pharmaceutical manufacturers to lower US drug prices in line with the Most Favored…
News
George Tidmarsh to sub in as FDA CBER head following Prasad’s shock exit
Dupixent sales spur Sanofi growth, but profits fall short
Dr Falk Pharma and Allianthera sign agreement for ATB102
African countries plan shift to healthcare funding autonomy amid aid cuts
Viridian and Kissei to advance veligrotug and VRDN-003 in Japan
Farxiga and Jardiance pose affordability issues, says Maryland drug board
Prasad’s FDA exit may accelerate cell and gene therapy approvals
